| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37405267c4b639215a35583ac31498bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca32fd2a44fd326ffd027a75a57bd13f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16052 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16 |
| filingDate |
2012-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36c4b072feca40064bb544c2ecb8204a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb86028d71dc9c8b6054e756a469031c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e5b94d9dad2443470f86e9ac1f3c525 |
| publicationDate |
2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2683820-T3 |
| titleOfInvention |
Use of non-subtype B GAG proteins for lentiviral encapsidation |
| abstract |
A replication defective lentiviral encapsidation vector that does not encode a functional HIV-1 Env and lacks a sitio site and encodes HIV-1 Gag-Pol selected from the group consisting of HIV-1 Gag-Pol from HIV-1 NDK or Gal-Pol of HIV-1 of a HIV-1 of subtype D, characterized in that the Gag-Pol protein comprises a portion of MA protein that has one or more of the following characteristics: the absence of an acid glutamic at amino acid position 12; the absence of an arginine at amino acid position 15; the absence of a valine at amino acid position 46; and the absence of leucine at amino acid position 61, where amino acid positions are numbered with respect to SEQ ID NO: 5. |
| priorityDate |
2011-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |